VolitionRx Limited Debt Instrument, Fair Value Disclosure
VolitionRx Limited (VNRX) had Debt Instrument, Fair Value Disclosure of $913.74 thousand as of 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Notes › Debt Instruments
us-gaap:DebtInstrumentFairValue · last filed 2026-03-31
- 2025-12-31: Debt Instrument, Fair Value Disclosure $913.74K.
- 2025-09-30: Debt Instrument, Fair Value Disclosure $432.12K.
- 2025-06-30: Debt Instrument, Fair Value Disclosure $764.40K.
- 2025-05-15: Debt Instrument, Fair Value Disclosure $1.04M.
| Period end | Debt Instrument, Fair Value Disclosure |
|---|---|
| 2025-12-31 | $913.74K 10-K · filed 2026-03-31 |
| 2025-09-30 | $432.12K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $764.40K 10-Q · filed 2025-08-14 |
| 2025-05-15 | $1.04M 10-K · filed 2026-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |